rs1554807812
Positions:
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate
The NM_000093.5(COL5A1):c.4656_4660del(p.Pro1553GlyfsTer2) variant causes a frameshift change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Pathogenic (★). Synonymous variant affecting the same amino acid position (i.e. G1552G) has been classified as Likely benign. Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: not found (cov: 34)
Consequence
COL5A1
NM_000093.5 frameshift
NM_000093.5 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 7.25
Genes affected
COL5A1 (HGNC:2209): (collagen type V alpha 1 chain) This gene encodes an alpha chain for one of the low abundance fibrillar collagens. Fibrillar collagen molecules are trimers that can be composed of one or more types of alpha chains. Type V collagen is found in tissues containing type I collagen and appears to regulate the assembly of heterotypic fibers composed of both type I and type V collagen. This gene product is closely related to type XI collagen and it is possible that the collagen chains of types V and XI constitute a single collagen type with tissue-specific chain combinations. The encoded procollagen protein occurs commonly as the heterotrimer pro-alpha1(V)-pro-alpha1(V)-pro-alpha2(V). Mutations in this gene are associated with Ehlers-Danlos syndrome, types I and II. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, May 2013]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 12 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 9-134823426-GCCCGA-G is Pathogenic according to our data. Variant chr9-134823426-GCCCGA-G is described in ClinVar as [Pathogenic]. Clinvar id is 459702.Status of the report is criteria_provided_single_submitter, 1 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
COL5A1 | NM_000093.5 | c.4656_4660del | p.Pro1553GlyfsTer2 | frameshift_variant | 61/66 | ENST00000371817.8 | |
LOC101448202 | NR_103451.2 | n.71-3222_71-3218del | intron_variant, non_coding_transcript_variant | ||||
COL5A1 | NM_001278074.1 | c.4656_4660del | p.Pro1553GlyfsTer2 | frameshift_variant | 61/66 | ||
COL5A1 | XM_017014266.3 | c.4656_4660del | p.Pro1553GlyfsTer2 | frameshift_variant | 61/65 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
COL5A1 | ENST00000371817.8 | c.4656_4660del | p.Pro1553GlyfsTer2 | frameshift_variant | 61/66 | 1 | NM_000093.5 | P4 | |
COL5A1 | ENST00000371820.4 | c.4656_4660del | p.Pro1553GlyfsTer2 | frameshift_variant | 61/66 | 2 | A2 | ||
COL5A1 | ENST00000460264.5 | n.124_128del | non_coding_transcript_exon_variant | 2/5 | 3 |
Frequencies
GnomAD3 genomes Cov.: 34
GnomAD3 genomes
Cov.:
34
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome Cov.: 34
GnomAD4 genome
Cov.:
34
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Ehlers-Danlos syndrome, classic type, 1 Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Mar 13, 2017 | For these reasons, this variant has been classified as Pathogenic. While this particular variant has not been reported in the literature, loss-of-function variants in COL5A1 are known to be pathogenic (PMID: 23587214). This sequence change deletes 5 nucleotides from exon 61 of the COL5A1 mRNA (c.4656_4660delCCCGA), causing a frameshift at codon 1553. This creates a premature translational stop signal (p.Pro1553Glyfs*2) and is expected to result in an absent or disrupted protein product. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at